Ber Gerard
Insider CIK 1762144 · LNTH Director · YMAB Director · PGNX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LNTH Lantheus Holdings, Inc. | A Award | 2026-05-14 | 2026-05-18 | 4,137 | — | $0 | 27,499 | SEC↗ |
| LNTH Lantheus Holdings, Inc. | F Tax w/h | 2026-05-14 | 2026-06-03 | 381 | $96.67 | $36.8K | 27,118 | SEC↗ |
| LNTH Lantheus Holdings, Inc. | A Award deriv | 2025-05-14 | 2025-05-16 | 4,543 | — | $0 | 4,543 | SEC↗ |
| LNTH Lantheus Holdings, Inc. | A Award | 2025-05-14 | 2025-05-16 | 2,537 | — | $0 | 23,362 | SEC↗ |
| LNTH Lantheus Holdings, Inc. | F Tax w/h | 2025-05-09 | 2025-05-13 | 396 | $81.74 | $32.4K | 20,825 | SEC↗ |
| LNTH Lantheus Holdings, Inc. | S Sale | 2024-08-12 | 2024-08-14 | 100 | $97.78 | $9.8K | 21,221 | SEC↗ |
| LNTH Lantheus Holdings, Inc. | S Sale | 2024-08-12 | 2024-08-14 | 11,175 | $96.23 | $1.08M | 25,546 | SEC↗ |
| LNTH Lantheus Holdings, Inc. | S Sale | 2024-08-12 | 2024-08-14 | 4,225 | $97.10 | $410.2K | 21,321 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2024-06-10 | 2024-06-11 | 722 | $12.00 | $8.7K | 1,608 | SEC↗ |
| LNTH Lantheus Holdings, Inc. | F Tax w/h | 2024-05-13 | 2024-05-15 | 302 | $77.88 | $23.5K | 36,721 | SEC↗ |
| LNTH Lantheus Holdings, Inc. | A Award deriv | 2024-05-09 | 2024-05-13 | 4,853 | — | $0 | 4,853 | SEC↗ |
| LNTH Lantheus Holdings, Inc. | A Award | 2024-05-09 | 2024-05-13 | 2,635 | — | $0 | 37,350 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | A Award deriv | 2023-06-08 | 2023-06-09 | 13,950 | — | $0 | 13,950 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | A Award | 2023-06-08 | 2023-06-09 | 2,330 | — | $0 | 2,330 | SEC↗ |
| LNTH Lantheus Holdings, Inc. | A Award deriv | 2023-05-11 | 2023-05-15 | 3,798 | — | $0 | 3,798 | SEC↗ |
| LNTH Lantheus Holdings, Inc. | A Award | 2023-05-11 | 2023-05-15 | 2,012 | — | $0 | 34,715 | SEC↗ |
| LNTH Lantheus Holdings, Inc. | F Tax w/h | 2023-05-08 | 2024-05-15 | 327 | $94.82 | $31.0K | 37,023 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | A Award deriv | 2022-07-15 | 2022-07-19 | 16,000 | — | $0 | 16,000 | SEC↗ |
| LNTH Lantheus Holdings, Inc. | S Sale | 2022-05-10 | 2022-05-12 | 1,277 | $58.19 | $74.3K | 32,703 | SEC↗ |
| LNTH Lantheus Holdings, Inc. | A Award deriv | 2022-05-06 | 2022-05-10 | 3,616 | — | $0 | 3,616 | SEC↗ |
| LNTH Lantheus Holdings, Inc. | A Award deriv | 2022-05-06 | 2022-05-12 | 4,068 | — | $0 | 4,068 | SEC↗ |
| LNTH Lantheus Holdings, Inc. | A Award | 2022-05-06 | 2022-05-10 | 2,180 | — | $0 | 33,980 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | A Award deriv | 2021-06-10 | 2021-06-14 | 16,000 | — | $0 | 16,000 | SEC↗ |
| LNTH Lantheus Holdings, Inc. | A Award | 2021-05-10 | 2021-05-12 | 8,513 | — | $0 | 31,800 | SEC↗ |
| LNTH Lantheus Holdings, Inc. | A Award | 2020-10-01 | 2020-10-05 | 1,065 | — | $0 | 23,287 | SEC↗ |
| LNTH Lantheus Holdings, Inc. | A Award | 2020-08-10 | 2020-08-12 | 741 | — | $0 | 22,222 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | A Award deriv | 2020-06-23 | 2020-06-24 | 16,000 | — | $0 | 16,000 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | D To issuer deriv | 2020-06-19 | 2020-06-23 | 16,393 | — | $0 | 0 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | D To issuer deriv | 2020-06-19 | 2020-06-23 | 40,000 | — | $0 | 0 | SEC↗ |
| LNTH Lantheus Holdings, Inc. | A Award deriv | 2020-06-19 | 2020-06-23 | 17,481 | — | $0 | 17,481 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | D To issuer | 2020-06-19 | 2020-06-23 | 50,000 | — | $0 | 0 | SEC↗ |
| LNTH Lantheus Holdings, Inc. | A Award | 2020-06-19 | 2020-06-23 | 15,500 | — | $0 | 21,481 | SEC↗ |
| LNTH Lantheus Holdings, Inc. | A Award | 2020-06-19 | 2020-06-23 | 5,981 | — | $0 | 5,981 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | A Award deriv | 2019-12-13 | 2019-12-17 | 40,000 | — | $0 | 40,000 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | A Award deriv | 2019-12-13 | 2019-12-17 | 16,393 | — | $0 | 16,393 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | A Award deriv | 2019-06-12 | 2019-06-14 | 16,000 | — | $0 | 16,000 | SEC↗ |